University of Kentucky selected as site for COVID-19 vaccine clinical trial


(Source: University of Oxford via CNN)

LEXINGTON, Ky. (WDKY) – The University of Kentucky has been chosen as a site for a COVID-19 vaccine trial.

It’s in partnership with Baptist Health Lexington and Northon Healthcare in Louisville.

Research teams need at least 2,000 local volunteers for the Phase 3 clinical trial.

It’s open to adults 18 and over who meet specific inclusion criteria.

Trending Stories

Latest Video

Latest News

More News